Fujian Haixi Pharmaceuticals Co., Ltd.
Status: Publicly traded
Direct answer
Fujian Haixi Pharmaceuticals Co., Ltd. is publicly traded on HKSE under the ticker 2637.HK.
Fujian Haixi Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical products in China. The company offers drugs for oncology, ophthalmology, respiratory, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It also provides pharmaceuticals technical services. In addition, the company offers generic alternatives, such as Anbili, a generic of...
Can you invest in Fujian Haixi Pharmaceuticals Co., Ltd.?
Yes. Fujian Haixi Pharmaceuticals Co., Ltd. trades publicly on HKSE as 2637.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Fujian Haixi Pharmaceuticals Co., Ltd.
Detailed equity research is provided by MarketSnap.